Colin Kavanagh, Head of the Life Sciences Group at Arthur Cox, discusses the current status of pricing and reimbursement of medicinal products for human use in Ireland, commonly of interest to companies. This practical comparative guide was first published by Conférence Bleue, a network of highly renowned lawyers specialising in pharmaceutical and health care law that meet regularly to exchange information.
To view the full article please click here.
This article contains a general summary of developments and is not a complete or definitive statement of the law. Specific legal advice should be obtained where appropriate.